- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02964026
Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients
February 15, 2017 updated by: Andrew Shaw, Vanderbilt University
Retrospective Analysis of Clinical Outcomes Associated With Use of the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients Within the Cerner HealthFacts Database
The primary objective for this retrospective Electronic Health Record (EHR) analysis is to evaluate the clinical outcomes associated with the utilization of a pulmonary artery catheter (PAC), for monitoring purposes, within patients undergoing cardiac surgeries (isolated coronary artery bypass graft [CABG], valve, aortic surgery, multi-procedures, other complex nonvalvular procedures and heart transplants).
The study will be conducted using prospectively collected hospital inpatient data over a duration of over 5 years (Jan.
1, 2010 - June 30, 2015) using a large US electronic health database (Cerner HealthFacts; Kansas City, MO).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
A retrospective study will be conducted using prospectively collected hospital inpatient data over a duration of over 5 years (Jan.
1, 2010 - June 30, 2015) using a large US electronic health database (Cerner HealthFacts; Kansas City, MO).
Patients who underwent a qualifying cardiac surgery (verified through use of selected valid International Classification of Diseases-9 procedure codes and/or Current Procedural Terminology [CPT] codes) will be included.
Each patient's cohort designation will be defined based upon whether he/she did or did not receive a pulmonary artery catheter (PAC) for monitoring purposes.
Propensity scores, which take into account patient and hospital demographics, patient comorbidities, surgical type (isolated coronary artery bypass graft [CABG], valve, aortic surgery, multi-procedures, other complex nonvalvular procedures and heart transplants), and pre-operative condition (via an adapted EuroSCORE II) will be utilized to "match" patients who received a PAC for monitoring purposes with those who did not, to form a matched study cohort.
Clinical outcomes will be monitored through index visit discharge and up to 90 days post index visit discharge.
Study Type
Observational
Enrollment (Actual)
6844
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult patients undergoing an isolated CABG, isolated valve, aortic procedure, complex nonvalvular procedures, multi-procedures or a heart transplant who receives or does not receive a pulmonary artery catheter (PAC) for monitoring purposes
Description
Inclusion Criteria:
- Patient undergoes a qualifying cardiac surgery between Jan 1, 2010 and January 1, 2015. If multiple qualifying surgeries are present, the first in database will be utilized
- Inpatient with a LOS of at least 48 hours
- Treated arm receives a PAC for monitoring purposes within admission date and qualifying cardiac surgical day plus one via specified ICD-9 or CPT-4 codes, or EHR recorded PAC readings
Exclusion Criteria:
- Cardiac surgery patients with age <18 years on index procedure date
- Non-treated arm derived from an institution which does not have database documented use of ICD-9 or CPT-4 PAC placement codes for monitoring purposes [Lessens the likelihood that the untreated arm is indeed treated by ensuring that the patient would likely be coded if he/she had a PAC in place for monitoring purposes]
- Patient record must have the demographics populated of age, gender, and race. ICD-9 diagnosis and procedure codes must be present in record for index visit, as well as medications administered over index visit
- Patient must be treated at a hospital which performs a minimum of 100 qualifying cardiac procedures per year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pulmonary artery catheter (PAC)
Patients received a PAC for monitoring purposes
|
PAC must be placed between the day of admission and the day following a qualifying cardiac surgery
Other Names:
|
|
No pulmonary artery catheter (PAC)
Patients did not receive a PAC for monitoring purposes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital mortality during index visit
Time Frame: Admission through up to 180 days (hospital discharge)
|
Admission through up to 180 days (hospital discharge)
|
|
|
Hospital length-of-stay (LOS)
Time Frame: Admission through up to 180 days (hospital discharge)
|
Index hospital visit LOS
|
Admission through up to 180 days (hospital discharge)
|
|
Hospital readmission
Time Frame: Through 30 days
|
Rate of hospital readmissions
|
Through 30 days
|
|
Hospital readmission
Time Frame: Through 60 days
|
Rate of hospital readmissions
|
Through 60 days
|
|
Hospital readmission
Time Frame: Through 90 days
|
Rate of hospital readmissions
|
Through 90 days
|
|
Major Adverse Cardiac Events (MACE)
Time Frame: Through 30 days
|
Through 30 days
|
|
|
Major Adverse Cardiac Events (MACE)
Time Frame: Through 60 days
|
Through 60 days
|
|
|
Major Adverse Cardiac Events (MACE)
Time Frame: Through 90 days
|
Through 90 days
|
|
|
Major morbidity composite
Time Frame: Through 30 days
|
Through 30 days
|
|
|
Major morbidity composite
Time Frame: Through 60 days
|
Through 60 days
|
|
|
Major morbidity composite
Time Frame: Through 90 days
|
Through 90 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
New organ failure (cardiovascular, respiratory, coagulation, liver systems, renal)
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
|
Requirement for mechanical ventilation
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
|
Hemorrhage requiring blood transfusion
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
|
Acute kidney injury (KDIGO staging)
Time Frame: Day 1 to day 10
|
Day 1 to day 10
|
|
Infectious complications
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
|
Gastrointestinal complication (hepatic)
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
|
Respiratory failure
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
|
Sequential Organ Failure Assessment (SOFA) scores
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
|
Neurologic complication
Time Frame: Day 1 to discharge (up to 180 days)
|
Day 1 to discharge (up to 180 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrew D Shaw, MB, FRCA, FFICM, FCCM, Vanderbilt University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2016
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
November 1, 2016
Study Registration Dates
First Submitted
October 18, 2016
First Submitted That Met QC Criteria
November 10, 2016
First Posted (Estimate)
November 15, 2016
Study Record Updates
Last Update Posted (Actual)
February 17, 2017
Last Update Submitted That Met QC Criteria
February 15, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 161377
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Surgery
-
Tribhuvan University Teaching Hospital, Institute...CompletedCardiac Surgery | Cardiac Surgery Requiring Cardiopulmonary BypassNepal
-
University of Sao Paulo General HospitalInstituto Dante Pazzanese de Cardiologia; Irmandade da Santa Casa de Misericordia... and other collaboratorsRecruitingCardiac Surgery | ERAS | Digital Health | Cardiac Surgery-CABGBrazil
-
Nationwide Children's HospitalCompleted
-
Shanghai Zhongshan HospitalRecruitingCardiac Surgery | Cardiac OutputChina
-
Asan Medical CenterCompleted
-
Universitätsklinikum Hamburg-EppendorfCompletedSerratus Anterior Plane Block | Minimal Invasive Cardiac Surgery | Minimal Invasive Cardiac Surgery Mitral Valve SurgeryGermany
-
Sheba Medical CenterTerminatedDisorder; Heart, Functional, Postoperative, Cardiac Surgery | Heart; Dysfunction Postoperative, Cardiac SurgeryIsrael
-
Nantes University HospitalCompletedCardiac Surgery Requiring Cardiopulmonary Bypass | Cardiac Surgery Under Extra Corporeal CirculationFrance
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Population Health Research Institute and other collaboratorsActive, not recruitingSurgery (Cardiac) | Surgery (Major Vascular)Canada, United Kingdom
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
Clinical Trials on pulmonary artery catheter
-
Monash UniversityNational Heart Foundation, Australia; Medical Research Future FundNot yet recruitingCardiac Surgery
-
Tufts Medical CenterRecruitingHeart Failure | Cardiogenic ShockUnited States
-
Norwegian University of Science and TechnologyCompleted
-
Peking Union Medical College HospitalUnknownSeptic Shock | Fluid Therapy | Hemodynamic InstabilityChina
-
Bicetre HospitalRecruitingARDS, Human | Ventilation Therapy; Complications | Alveolar; DisorderFrance
-
National Heart, Lung, and Blood Institute (NHLBI)ARDSNetCompletedLung Diseases | Acute Respiratory Distress Syndrome
-
Assiut UniversityNot yet recruitingCardiac Output, Low
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI); Agency for Healthcare Research...CompletedLung Diseases | Acute Respiratory Distress Syndrome | Acute Lung Injury
-
Massachusetts General HospitalTerminatedMixed Venous Oxygen Saturation | Tissue OxygenationUnited States